Microbiology
-
Site-specific analysis of the SARS-CoV-2 glycan shield
This article has 5 authors:Reviewed by ScreenIT
-
Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity
This article has 5 authors:Reviewed by ScreenIT
-
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-domain Camelid Antibodies
This article has 15 authors:Reviewed by ScreenIT
-
Topoisomerase III-ß is required for efficient replication of positive-sense RNA viruses
This article has 15 authors:Reviewed by ScreenIT
-
Broad anti-coronaviral activity of FDA approved drugs against SARS-CoV-2 in vitro and SARS-CoV in vivo
This article has 6 authors:Reviewed by ScreenIT
-
SARS-CoV-2 launches a unique transcriptional signature from in vitro, ex vivo, and in vivo systems
This article has 8 authors:Reviewed by ScreenIT
-
Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site
This article has 11 authors:Reviewed by ScreenIT
-
SARS-CoV-2, an evolutionary perspective of interaction with human ACE2 reveals undiscovered amino acids necessary for complex stability
This article has 4 authors:Reviewed by ScreenIT
-
Emergence of SARS-CoV-2 through Recombination and Strong Purifying Selection
This article has 9 authors:Reviewed by ScreenIT
-
Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del)
This article has 14 authors:Reviewed by ScreenIT